Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 75,000 shares at $40.06 ($3.0M) on 2020-12-10, disclosed to the SEC on 2020-12-14.
Open-market sale of $3.0M RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.06 | 22,584 | $905K | 30.1% |
| 2 | $40.06 | 22,584 | $905K | 30.1% |
| 3 | $40.17 | 14,916 | $599K | 19.9% |
| 4 | $40.17 | 14,916 | $599K | 19.9% |
| Total | $40.10 avg | 75,000 | $3.0M | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |